Osteoarthritis Trial, Recruiting NCT04228419 Sponsor: Ottawa Hospital Research Institute Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT04228419
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have shoulder arthritis (of unknown cause) and have tried non-surgical treatments for at least 6 months without enough relief from pain or difficulty moving your shoulder
  • Your non-surgical treatment must have included pain or anti-inflammatory medications, physiotherapy (such as stretching, strengthening, and treatments like ultrasound or ice therapy), and changes to your daily activities
  • Scans and surgical findings show significant loss of cartilage in your shoulder joint
  • You may have some bone loss or abnormal positioning of the shoulder socket, as long as the socket is not tilted back more than 15 degrees
  • You are 65 years of age or older

Who may not be able to join:

  • You currently have an active infection in your joint or anywhere in your body
  • Your shoulder condition involves damage to the tendons surrounding your shoulder joint (known as rotator cuff arthropathy)
  • You have significant weakness or loss of function in the muscles around your shoulder
  • You have a nerve-related joint condition that causes joint damage (confirm with trial site)
  • You have a serious medical illness that significantly shortens your life expectancy or makes surgery too risky
  • You are unable to understand or go through the process of giving your consent to participate
  • You are pregnant
  • You have a psychiatric illness that prevents you from giving informed consent
  • You are not willing to attend follow-up appointments for the full length of the study
  • The position of your shoulder socket cannot be corrected closely enough to normal during surgery (confirm with trial site)
  • You have had previous surgery on the shoulder being studied

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Peter Lapner, MD, The Ottawa Hospital

Phone: 613-737-8899

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ottawa Hospital Research Institute
Registry
ClinicalTrials.gov
Start date
9 March 2020
Est. completion
1 January 2030

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Western Ontario Osteoarthritis of the Shoulder Index (WOOS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov